Use the Back button in your browser to see the other results of your search or to select another record.
Manual hyperinflation combined with expiratory rib cage compression for reduction of length of ICU stay in critically ill patients on mechanical ventilation |
Berti JSW, Tonon E, Ronchi CF, Berti HW, de Stefano LM, Gut AL, Padovani CR, Ferreira ALA |
Jornal Brasileiro de Pneumologia 2012 Jul-Aug;38(4):477-486 |
clinical trial |
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
OBJECTIVE: Although manual hyperinflation (MH) is widely used for pulmonary secretion clearance, there is no evidence to support its routine use in clinical practice. Our objective was to evaluate the effect that MH combined with expiratory rib cage compression (ERCC) has on the length of ICU stay and duration of mechanical ventilation (MV). METHODS: This was a prospective randomized controlled clinical trial involving ICU patients on MV at a tertiary care teaching hospital between January of 2004 and January of 2005. Among the 49 patients who met the study criteria, 24 and 25 were randomly assigned to the respiratory physiotherapy (RP) and control groups, respectively. Of those same patients, 6 and 8, respectively, were later withdrawn from the study. During the 5-day observation period, the RP patients received MH combined with ERCC, whereas the control patients received standard nursing care. RESULTS: The two groups were similar in terms of the baseline characteristics. The intervention had a positive effect on the duration of MV, as well as on the ICU discharge rate and Murray score. There were significant differences between the control and RP groups regarding the weaning success rate on days 2 (0.0% versus 37.5%), 3 (0.0% versus 37.5%), 4 (5.3% versus 37.5%), and 5 (15.9% versus 37.5%), as well as regarding the ICU discharge rate on days 3 (0% versus 25%), 4 (0% versus 31%), and 5 (0% versus 31%). In the RP group, there was a significant improvement in the Murray score on day 5. CONCLUSIONS: Our results show that the use of MH combined with ERCC for 5 days accelerated the weaning process and ICU discharge.
|